Huvitz Co., Ltd. (KOSDAQ:065510)
9,000.00
+110.00 (1.24%)
At close: Feb 4, 2026
Huvitz Revenue
Huvitz had revenue of 31.50B KRW in the quarter ending September 30, 2025, with 5.21% growth. This brings the company's revenue in the last twelve months to 120.56B, up 3.53% year-over-year. In the year 2024, Huvitz had annual revenue of 117.88B with 0.12% growth.
Revenue (ttm)
120.56B
Revenue Growth
+3.53%
P/S Ratio
0.76
Revenue / Employee
461.92M
Employees
261
Market Cap
92.08B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 117.88B | 138.16M | 0.12% |
| Dec 31, 2023 | 117.74B | 8.96B | 8.23% |
| Dec 31, 2022 | 108.78B | 13.76B | 14.48% |
| Dec 31, 2021 | 95.02B | 24.93B | 35.57% |
| Dec 31, 2020 | 70.09B | -17.90B | -20.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NVH Korea | 1.64T |
| Wooree Bio Co.,Ltd | 1.08T |
| SEOWONINTECH. | 209.50B |
| STraffic Co,. | 189.59B |
| Assems | 62.19B |
| Cell Biotech | 50.65B |
| JASTECH | 34.69B |
| Xperix | 19.78B |